Provided by Tiger Trade Technology Pte. Ltd.

Day One Biopharmaceuticals Inc.

8.25
-0.0200-0.24%
Pre-market: 8.520.2700+3.27%06:18 EST
Volume:5.43M
Turnover:45.57M
Market Cap:847.07M
PE:-5.59
High:8.73
Open:8.28
Low:8.25
Close:8.27
52wk High:13.53
52wk Low:5.64
Shares:102.68M
Float Shares:78.77M
Volume Ratio:2.19
T/O Rate:6.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4748
EPS(LYR):-1.0243
ROE:-30.16%
ROA:-18.57%
PB:1.88
PE(LYR):-8.05

Loading ...

Nov 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Oct 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]